The effects of paraoxonase (PON1) polymorphisms in the coding region and environmental factors on serum PON1 activity

被引:0
|
作者
Jintana, Sirivarasai
Sming, Kaojarern
Krongtong, Yoovathawom
Thanyachai, Sura
机构
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Clin Pharmacol & Toxicol, Bangkok 10400, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Med Genet, Bangkok 10400, Thailand
[3] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P53
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [1] Effects of Intronic and Exonic Polymorphisms of Paraoxonase 1 (PON1) Gene on Serum PON1 Activity in a Korean Population
    Eom, Sang-Yong
    Kim, Yun-Sik
    Lee, Chung-Jong
    Lee, Chul-Ho
    Kim, Yong-Dae
    Kim, Heon
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (06) : 720 - 725
  • [2] Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
    Mackness, Bharti
    Turkie, Wajdi
    Mackness, Mike
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (01) : 8 - 13
  • [3] PARAOXONASE 1 (PON1) GENE POLYMORPHISMS, PON1 EXPRESSION IN PBMCS, AND SERUM PON1 ACTIVITY CONCERNING DYSLIPIDEMIA AND RELATED COMORBIDITIES IN HEMODIALYSIS (HD) PATIENTS
    Grzegorzewska, Alicja Ewa
    Lwanczyk-Skalska, Ewa
    Adamska, Paulina
    Niepolski, Leszek
    Mostowska, Adrianna
    Warchol, Wojciech
    Jagodzinski, Pawel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1598 - 1598
  • [4] Paraoxonase (PON1) enzyme activity predicts vascular disease independently of PON1 promoter region or coding polymorphisms and of smoking and antihyperlipidemic use
    Jarvik, GP
    Heagerty, P
    Hatsukami, T
    Furlong, CE
    [J]. CIRCULATION, 2002, 105 (14) : E91 - E91
  • [5] GENETIC POLYMORPHISM IN PARAOXONASE 1 (PON1): POPULATION DISTRIBUTION OF PON1 ACTIVITY
    Ginsberg, Gary
    Neafsey, Patricia
    Hattis, Dale
    Guyton, Kathryn Z.
    Johns, Douglas O.
    Sonawane, Babasaheb
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 473 - 507
  • [6] SERUM PARAOXONASE ACTIVITY AND PON1 192 AND PON1 55 POLYMORPHISMS IN PREPUBERAL CHILDREN. THE FOUR PROVINCES STUDY
    Garces, Carmen
    Lopez-Simon, Laura
    Rubio, Rafael
    Benavente, Mercedes
    Cano, Beatriz
    Viturro, Enrique
    de Oya, Manuel
    del Barrio, J. L.
    de Oya, I.
    Lasuncion, M. A.
    Ortega, H.
    Martin Moreno, J. M.
    Gorgojo, L.
    Royo, M. A.
    Gil, A.
    Rodriguez Artalejo, F.
    Fernandez, O.
    Mangas, A.
    Macias, A.
    Fernandez Pardo, J.
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2007, 19 (06): : 287 - 292
  • [7] Functional genomics of the paraoxonase (PON1) polymorphisms
    Cole, TB
    Jarvik, GP
    Richter, RJ
    Jampsa, RL
    Carlson, CS
    Rieder, MJ
    Nickerson, DA
    Shih, DM
    Lusis, AJ
    Costa, LG
    Furlong, CE
    [J]. FASEB JOURNAL, 2003, 17 (04): : A158 - A158
  • [8] Modulation of paraoxonase (PON1) activity
    Costa, LG
    Vitalone, A
    Cole, TB
    Furlong, CE
    [J]. BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) : 541 - 550
  • [9] Polymorphisms in the human paraoxonase (PON1) promoter
    Brophy, VH
    Hastings, MD
    Clendenning, JB
    Richter, RJ
    Jarvik, GP
    Furlong, CE
    [J]. PHARMACOGENETICS, 2001, 11 (01): : 77 - 84
  • [10] Human paraoxonase (PON1) polymorphisms in Taiwanese
    Li, WF
    Chung, MC
    Chuang, HY
    Chang, LW
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 66 - 66